N/A
Completed N=81
Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses
Source: ClinicalTrials.gov NCT03971578 ↗Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcomePrimary: ABR Peak V Latency — 6; 5.8; 6.29; 5.99 ms
Summary
The purpose of this study is to develop an Auditory Brainstem Response (ABR) based neurological screening method to detect increased risk for Autism Spectrum Disorders (ASD) and other neurological conditions in newborns.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY ABR Peak V Latency |
6; 5.8; 6.29; 5.99; 6.48; 6.26 | — |
Eligibility Criteria
Inclusion Criteria
- Children with autism spectrum disorder diagnosis
- Normally developing age- and gender-matched controls
Exclusion Criteria
- Permanent or temporary hearing loss at the time of testing.
- Craniofacial abnormalities
Data sourced from ClinicalTrials.gov (NCT03971578). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.